Literature DB >> 23183880

Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.

Chor Sang Chim, Pak Tat Choi, Wai Ki Lee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23183880     DOI: 10.1007/s00277-012-1639-3

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


× No keyword cloud information.
  2 in total

1.  Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.

Authors:  Richard J Jones; Tawin Iempridee; Xiaobin Wang; Hans C Lee; Janet E Mertz; Shannon C Kenney; Heather C Lin; Veerabhadran Baladandayuthapani; Christopher W Dawson; Jatin J Shah; Donna M Weber; Robert Z Orlowski
Journal:  Clin Cancer Res       Date:  2016-06-13       Impact factor: 12.531

2.  EBV-positive Diffuse Large B-cell Lymphoma as a Secondary Malignancy Arising in a Myelodysplastic Syndrome Patient who Was Treated with Azacitidine.

Authors:  Naruko Suzuki; Junji Hiraga; Hiroki Kato; Yusuke Takagi; Nobuko Ujihira; Michihiko Narita; Yoshitoyo Kagami
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.